Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P. | Institution | 12.273.280 | 8,64% | US$ 239,33M | 2026-05-05 |
| New Enterprise Associates, Inc. | Institution | 12.273.280 | 8,64% | US$ 239,33M | 2026-05-05 |
| BlackRock, Inc. | Institution | 10.240.186 | 7,21% | US$ 199,68M | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 9.939.547 | 7,00% | US$ 193,82M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 8.508.021 | 5,99% | US$ 165,91M | 2025-03-31 |
| FMR LLC | Institution | 8.037.349 | 5,66% | US$ 156,73M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 5.189.088 | 3,65% | US$ 101,19M | 2026-03-31 |
| Vivo Capital, LLC | Institution | 5.094.668 | 3,59% | US$ 99,35M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 4.978.567 | 3,51% | US$ 97,08M | 2026-03-31 |
| Marshall Wace LLP | Institution | 3.966.019 | 2,79% | US$ 77,34M | 2026-03-31 |
| Rubric Capital Management LP | Institution | 3.712.373 | 2,61% | US$ 72,39M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 3.298.430 | 2,32% | US$ 64,32M | 2026-03-31 |
| Viking Global Investors LP | Institution | 3.198.644 | 2,25% | US$ 62,37M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 3.102.058 | 2,18% | US$ 60,49M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 2.845.472 | 2,00% | US$ 55,49M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 2.778.231 | 1,96% | US$ 54,18M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 2.665.313 | 1,88% | US$ 51,97M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 2.622.306 | 1,85% | US$ 51,13M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 2.454.400 | 1,73% | US$ 47,86M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 2.400.000 | 1,69% | US$ 46,80M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 2.166.504 | 1,53% | US$ 42,25M | 2026-03-31 |
| Acorn Bioventures | Institution | 2.144.844 | 1,51% | US$ 41,82M | 2026-03-31 |
| Artia Global Partners LP | Institution | 2.013.602 | 1,42% | US$ 39,27M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 2.000.172 | 1,41% | US$ 39,00M | 2026-03-31 |
| Frontier Capital Management Co LLC | Institution | 1.994.292 | 1,40% | US$ 38,89M | 2026-03-31 |
| Artal Group S.A. | Institution | 1.786.867 | 1,26% | US$ 34,84M | 2026-03-31 |
| Pictet Asset Management Limited | Institution | 1.706.048 | 1,20% | US$ 33,27M | 2026-03-31 |
| Raymond James Financial, Inc. | Institution | 1.687.977 | 1,19% | US$ 32,92M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 1.620.000 | 1,14% | US$ 31,59M | 2026-03-31 |
| Pivotal BioVenture Partners LLC | Institution | 1.553.726 | 1,09% | US$ 30,30M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 1.485.000 | 1,05% | US$ 28,96M | 2026-03-31 |
| Frazier Life Sciences XI, L.P. | Institution | 1.354.079 | 0,95% | US$ 26,40M | 2025-03-31 |
| Citadel Advisors LLC | Institution | 1.201.489 | 0,85% | US$ 23,43M | 2026-03-31 |
| Nan Fung Trinity (HK) Limited | Institution | 1.142.950 | 0,81% | US$ 22,29M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1.119.826 | 0,79% | US$ 21,84M | 2026-03-31 |
| Bank of America Corporation | Institution | 1.116.085 | 0,79% | US$ 21,76M | 2026-03-31 |
| F. L. Putnam Investment Management Co. | Institution | 1.063.301 | 0,75% | US$ 20,73M | 2026-03-31 |
| Rosalind Master Fund L.P. | Institution | 1.062.500 | 0,75% | US$ 20,72M | 2025-02-13 |
| Woodline Partners LP | Institution | 1.000.782 | 0,70% | US$ 19,52M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 968.588 | 0,68% | US$ 18,89M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
